Sep 7, 2018

Two recent studies challenge our current approach to managing patients with mild persistent asthma. When patients with asthma are prescribed inhaled corticosteroids (ICSs), we instruct them to use the medication daily.

Comments: 0
Jul 14, 2018

We’ve been managing asthma, for the most part, the same way for quite some time now … short acting beta agonist (SABA) for quick relief, inhaled corticosteroids (ICS) as first line maintenance treatment, step up if needed, step down if possible … plus self-management education and a written asthma action plan.  Despite many treatment options, numerous adults, adolescents, and children still suffer from asthma exacerbations, leading to reduced quality of life, missed work and school, higher co

Comments: 0
Nov 26, 2017

Asthma costs the US health care system roughly 50 billion dollars annually.1 And patients with uncontrolled severe asthma (> 2 exacerbations per year) incur far more cost than patients with persistent asthma without exacerbations ($5174 vs $1775 in 2013).2 Despite good adherence with high-dose inhaled corticosteroids (ICS) and concomitant long-acting beta agonists (LABA), millions of people continue to experience exacerbations.3  What more can patients and

Comments: 0
May 19, 2017

A recent study evaluated the use of fish oil (EPA/DHA) supplementation during the 3rd trimester of pregnancy to prevent the development of wheezing and asthma in children.  Does it work?  Who should receive fish oil supplementation during pregnancy?  Watch this vidcast and find out!


Comments: 0
Sep 20, 2015

To treat acute asthma exacerbations in children, how about a single dose of dexamethasone and your done!  Sounds simple, easy, and convenient.  But is it too good to be true?

Comments: 0
Mar 9, 2015

Can deploying trained laypeople working directly with low income adults with asthma in the community improve outcomes?

Comments: 0
Feb 18, 2013

The PrimoTinA - asthma studies are two replicate double-blind clinical trials examining the benefits of adding inhaled  tiotropium to standard asthma therapies in patients who have not achieved optimal control.  Our moderator and panelists explore the findings of this study and how this new information should be applied to practice.

Comments: 1
Jan 13, 2011

Step one, short-acting beta agonists (SABA) as needed.  Step two: low dose inhaled corticosteroids (ICS).

Comments: 0